human plgf 2 Search Results


92
MedChemExpress pgf
Pgf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pgf/product/MedChemExpress
Average 92 stars, based on 1 article reviews
pgf - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
R&D Systems human plgf 2
Human Plgf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human plgf 2/product/R&D Systems
Average 93 stars, based on 1 article reviews
human plgf 2 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

94
Rockland Immunochemicals koa0292
Koa0292, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/koa0292/product/Rockland Immunochemicals
Average 94 stars, based on 1 article reviews
koa0292 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

92
OriGene pcmv6 ac plgf cat sc320206 plasmids
Sustained hBM-MSC growth and secretion of placental growth factor after TransIT-2020 transfection. (a) Representative 20X phase contrast images showing cell morphology of hBM-MSCs with reagent only control (R) and the 4h-OM condition with either the <t>pCMV6</t> empty control or pCMV6-PlGF vector. Scale bars represent 200 μ m. (b) Quantification of PlGF secretion per well in a 6-well plate (pg/ml) in the hBM-MSC cell-conditioned media 24 hours after transfection by ELISA. (c) Amount of viable cells present 24 hours after transfection expressed as a percentage of initial seeding density in a 6-well plate. (d) Percentage of viable cells after transfection in a 6-well plate. (e) Quantification of PlGF secretion (pg/ml) per T75 flask. (f) Amount of viable cells present 24 hours after transfection in a T75. (g) Percentage of viable cells after transfection in a T75. (h) Secretion of PlGF (pg/ml) throughout the 7 days after transfection. (i) Amount of cell growth up to 7 days after transfection, expressed as a percentage of viable cells measured divided by the initial seeding of 37,500 cells. Results from 3 (a–d) or 4 (e–i) independent experiments with technical duplicates. Error bars represent S.E.M. Statistical significance was obtained using a one-tailed t -test for (b) and a two-way ANOVA with a Bonferroni post hoc analysis for (f–g). ∗ p < 0.05 and ∗∗ p < 0.01.
Pcmv6 Ac Plgf Cat Sc320206 Plasmids, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcmv6 ac plgf cat sc320206 plasmids/product/OriGene
Average 92 stars, based on 1 article reviews
pcmv6 ac plgf cat sc320206 plasmids - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

90
Reliatech polyclonal rabbit anti–plgf-2 antibody
Sustained hBM-MSC growth and secretion of placental growth factor after TransIT-2020 transfection. (a) Representative 20X phase contrast images showing cell morphology of hBM-MSCs with reagent only control (R) and the 4h-OM condition with either the <t>pCMV6</t> empty control or pCMV6-PlGF vector. Scale bars represent 200 μ m. (b) Quantification of PlGF secretion per well in a 6-well plate (pg/ml) in the hBM-MSC cell-conditioned media 24 hours after transfection by ELISA. (c) Amount of viable cells present 24 hours after transfection expressed as a percentage of initial seeding density in a 6-well plate. (d) Percentage of viable cells after transfection in a 6-well plate. (e) Quantification of PlGF secretion (pg/ml) per T75 flask. (f) Amount of viable cells present 24 hours after transfection in a T75. (g) Percentage of viable cells after transfection in a T75. (h) Secretion of PlGF (pg/ml) throughout the 7 days after transfection. (i) Amount of cell growth up to 7 days after transfection, expressed as a percentage of viable cells measured divided by the initial seeding of 37,500 cells. Results from 3 (a–d) or 4 (e–i) independent experiments with technical duplicates. Error bars represent S.E.M. Statistical significance was obtained using a one-tailed t -test for (b) and a two-way ANOVA with a Bonferroni post hoc analysis for (f–g). ∗ p < 0.05 and ∗∗ p < 0.01.
Polyclonal Rabbit Anti–Plgf 2 Antibody, supplied by Reliatech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti–plgf-2 antibody/product/Reliatech
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti–plgf-2 antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

N/A
Placenta growth factor PGF Isoform PlGF 2 human recombinant protein 20 µg
  Buy from Supplier

N/A
Recombinant Human PLGF-2 (carrier-free) Apps: BA; Size: 10 μg
  Buy from Supplier

N/A
PlGF-2, Recombinant Human; 5 ug
  Buy from Supplier



N/A
RayBio® Custom Human PlGF-2 ELISA Kit. 5 - 7 week lead time.
  Buy from Supplier

Image Search Results


Sustained hBM-MSC growth and secretion of placental growth factor after TransIT-2020 transfection. (a) Representative 20X phase contrast images showing cell morphology of hBM-MSCs with reagent only control (R) and the 4h-OM condition with either the pCMV6 empty control or pCMV6-PlGF vector. Scale bars represent 200 μ m. (b) Quantification of PlGF secretion per well in a 6-well plate (pg/ml) in the hBM-MSC cell-conditioned media 24 hours after transfection by ELISA. (c) Amount of viable cells present 24 hours after transfection expressed as a percentage of initial seeding density in a 6-well plate. (d) Percentage of viable cells after transfection in a 6-well plate. (e) Quantification of PlGF secretion (pg/ml) per T75 flask. (f) Amount of viable cells present 24 hours after transfection in a T75. (g) Percentage of viable cells after transfection in a T75. (h) Secretion of PlGF (pg/ml) throughout the 7 days after transfection. (i) Amount of cell growth up to 7 days after transfection, expressed as a percentage of viable cells measured divided by the initial seeding of 37,500 cells. Results from 3 (a–d) or 4 (e–i) independent experiments with technical duplicates. Error bars represent S.E.M. Statistical significance was obtained using a one-tailed t -test for (b) and a two-way ANOVA with a Bonferroni post hoc analysis for (f–g). ∗ p < 0.05 and ∗∗ p < 0.01.

Journal: Stem Cells International

Article Title: Efficient Nonviral Transfection of Human Bone Marrow Mesenchymal Stromal Cells Shown Using Placental Growth Factor Overexpression

doi: 10.1155/2018/1310904

Figure Lengend Snippet: Sustained hBM-MSC growth and secretion of placental growth factor after TransIT-2020 transfection. (a) Representative 20X phase contrast images showing cell morphology of hBM-MSCs with reagent only control (R) and the 4h-OM condition with either the pCMV6 empty control or pCMV6-PlGF vector. Scale bars represent 200 μ m. (b) Quantification of PlGF secretion per well in a 6-well plate (pg/ml) in the hBM-MSC cell-conditioned media 24 hours after transfection by ELISA. (c) Amount of viable cells present 24 hours after transfection expressed as a percentage of initial seeding density in a 6-well plate. (d) Percentage of viable cells after transfection in a 6-well plate. (e) Quantification of PlGF secretion (pg/ml) per T75 flask. (f) Amount of viable cells present 24 hours after transfection in a T75. (g) Percentage of viable cells after transfection in a T75. (h) Secretion of PlGF (pg/ml) throughout the 7 days after transfection. (i) Amount of cell growth up to 7 days after transfection, expressed as a percentage of viable cells measured divided by the initial seeding of 37,500 cells. Results from 3 (a–d) or 4 (e–i) independent experiments with technical duplicates. Error bars represent S.E.M. Statistical significance was obtained using a one-tailed t -test for (b) and a two-way ANOVA with a Bonferroni post hoc analysis for (f–g). ∗ p < 0.05 and ∗∗ p < 0.01.

Article Snippet: pCMV6-AC-GFP (cat.#PS100010) and pCMV6-AC-PlGF (cat.#SC320206) plasmids were purchased from OriGene (Rockville, MD, USA). pCMV6-AC-GFP was amplified using Alpha-Gold competent cells (cat.#CC100001, OriGene) and the pCMV6-AC empty vector was generated from glycerol stocks (cat.#PS200020-GLY, OriGene).

Techniques: Transfection, Plasmid Preparation, Enzyme-linked Immunosorbent Assay, One-tailed Test